Moran Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.84M Buy
32,861
+4,246
+15% +$353K 0.08% 275
2026
Q2
$1.93M Sell
28,615
-1,361
-5% -$90.7K 0.05% 331
2026
Q1
$1.88M Sell
29,976
-164,029
-85% -$11.4M 0.06% 318
2025
Q4
$12.9M Buy
194,005
+40,672
+27% +$2.63M 0.39% 78
2025
Q3
$10.3M Buy
153,333
+125,104
+443% +$9.9M 0.31% 100
2025
Q2
$2.46M Buy
+28,229
New +$2.21M 0.08% 266
2024
Q3
– Sell
-3,546
Closed -$402K – 413
2024
Q2
$402K Buy
3,546
+1,236
+54% +$156K 0.01% 357
2024
Q1
$320K Buy
+2,310
New +$290K 0.01% 370

Other funds holding DXCM

Moran Wealth Management's DXCM Position: Q3 2026 in Review

Moran Wealth Management increased its DexCom (DXCM) stake by 15% in Q3 2026, buying an estimated $353K and bringing the position to 32,861 shares worth $2.84M. The position accounts for 0.08% of the portfolio, ranked #275.

Moran Wealth Management first reported a position in DXCM in Q1 2024 and has held it in 8 quarters since. The position peaked at $12.9M in Q4 2025. 192 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Moran Wealth Management held 32,861 shares of DexCom worth $2.84M as of Q3 2026.
  • Moran Wealth Management bought 4,246 DexCom shares in Q3 2026, an estimated $353K.
  • DexCom made up 0.08% of Moran Wealth Management's portfolio in Q3 2026, its #275 holding.
  • Moran Wealth Management first reported a position in DexCom in Q1 2024 and has held it in 8 quarters since.
  • Moran Wealth Management's DexCom position peaked at $12.9M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Moran Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.